What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?

被引:79
作者
Berkkanoglu, Murat [1 ]
Ozgur, Kemal [1 ]
机构
[1] Antalya IVF Ctr, Antalya, Turkey
关键词
Recombinant FSH; microdose cycle; pregnancy rate; poor responders; FOLLICLE-STIMULATING-HORMONE; IN-VITRO FERTILIZATION; OVULATION INDUCTION; OVARIAN STIMULATION; IVF; FSH; PROTOCOL; AGONIST; PHASE; MANAGEMENT;
D O I
10.1016/j.fertnstert.2009.03.027
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To find out the optimum maximal dosage of recombinant follicle stimulating hormone (rFSH) in microdose gonadotropin-releasing hormone analog (GnRH-a) flare cycles in poor responders. Design: Prospective randomized study. Setting: Private infertility clinic. Patient(s): A total of 119 women were taken into the study. Intervention(s): The study group underwent a microdose protocol with a GnRH-agonist followed by rFSH administration. On the third day of GnRH-a administration, 119 patients were randomized in three groups to receive daily fixed doses of 300 IU of rFSH(group A, n = 38), or 450 IU of rFSH(group B, n = 39), or 600 IU of rFSH (group C, n = 42). Main Outcome Measure(s): Peak E-2 levels, days of stimulation with rFSH, total rFSH dosage, total number of oocytes retrieved, M2 oocytes retrieved, total number of embryos, number of embryos transferred, number of Grade-1 embryos transferred, clinical pregnancy rate (positive fetal cardiac activity), and cancellation rates of stimulation and embryo transfer. Result(s): Clinical pregnancy rates were 13.1%, 15.3%, and 16.1% for group A, group B, and group C, respectively. There were no significant differences in the age, peak serum E-2 concentration, days of stimulation with rFSH, total number of M2 oocytes retrieved, number of embryos transferred, clinical pregnancy rates, and cancellation rates of stimulation and embryo transfer between the three groups except for total rFSH dosage. Conclusion(s): There is no need to use doses above 300 IU of rFSH to increase the pregnancy rate in microdose cycles. In addition, because the duration of stimulation does not differ between the groups, the usage of 300 IU rFSH in microdose cycles results in less total amount of rFSH consumed in a cycle compared with higher dosages, and this would obviously cost less money to the patients. (Fertil Steril (R) 2010;94:662-5. (C) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:662 / 665
页数:4
相关论文
共 34 条
[1]   Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve [J].
Bancsi, LFJMM ;
Broekmans, FJM ;
Eijkemans, MJC ;
de Jong, FH ;
Habbema, JDF ;
te Velde, ER .
FERTILITY AND STERILITY, 2002, 77 (02) :328-336
[2]  
BENRAFAEL Z, 1987, FERTIL STERIL, V48, P964
[3]   Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders [J].
Berkkanoglu, Murat ;
Isikoglu, Mete ;
Aydin, Donay ;
Ozgur, Kemal .
FERTILITY AND STERILITY, 2007, 88 (03) :665-669
[4]   Tailoring FSH and LH administration to individual patients [J].
Borini, A ;
Dal Prato, L .
REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (03) :283-293
[5]   GnRHa flare and IVF pregnancy rates [J].
Confino, E ;
Zhang, X ;
Kazer, RR .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 85 (01) :36-39
[6]  
*CTR CLIN EFF, 2000, COCHRANE DB SYST REV
[7]   Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH [J].
de Koning, CH ;
Popp-Snijders, C ;
Schoemaker, J ;
Lambalk, CB .
HUMAN REPRODUCTION, 2000, 15 (07) :1452-1456
[8]   FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level? [J].
Dorn, C .
REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (05) :555-561
[9]   Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders [J].
Faber, BM ;
Mayer, J ;
Cox, B ;
Jones, D ;
Toner, JP ;
Oehninger, S ;
Muasher, SJ .
FERTILITY AND STERILITY, 1998, 69 (05) :826-830
[10]   Gonadotropin-releasing hormone analogs in ovulation induction: Current status and perspectives [J].
Filicori, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07) :2413-2416